{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:21:51Z","timestamp":1787440911749,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A04J1278"],"award-info":[{"award-number":["2023A04J1278"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0515"],"award-info":[{"award-number":["2023A03J0515"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0516"],"award-info":[{"award-number":["2023A03J0516"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300965"],"award-info":[{"award-number":["82300965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119574","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:59:59Z","timestamp":1779832799000},"page":"119574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ceramide: A critical lipid mediator in the progression of diabetic nephropathy"],"prefix":"10.1016","volume":"200","author":[{"given":"Yunhao","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luona","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119574_bib1","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2021","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.biopha.2026.119574_bib2","doi-asserted-by":"crossref","DOI":"10.2147\/DMSO.S507171","article-title":"Advances in the epigenetic mechanisms of diabetic nephropathy pathogenesis","volume":"18","author":"Zhang","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"12","key":"10.1016\/j.biopha.2026.119574_bib3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00424-024-03029-5","article-title":"The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives","volume":"476","author":"Schwalm","year":"2024","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2026.119574_bib4","doi-asserted-by":"crossref","DOI":"10.4062\/biomolther.2020.204","article-title":"Diabetic nephropathy - a review of risk factors, progression, mechanism, and dietary management","volume":"29","author":"Natesan","year":"2021","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.biopha.2026.119574_bib5","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc. Dis. Re"},{"key":"10.1016\/j.biopha.2026.119574_bib6","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.95216","article-title":"Lipid homeostasis in diabetic kidney disease","volume":"20","author":"Wang","year":"2024","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119574_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjms.2019.11.004","article-title":"Renal lipid metabolism and lipotoxicity in diabetes","volume":"359","author":"Thongnak","year":"2020","journal-title":"Am J. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119574_bib8","doi-asserted-by":"crossref","DOI":"10.1042\/CS20180702","article-title":"Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2026.119574_bib9","doi-asserted-by":"crossref","DOI":"10.4330\/wjc.v17.i2.102308","article-title":"Emerging roles of the acid sphingomyelinase\/ceramide pathway in metabolic and cardiovascular diseases: mechanistic insights and therapeutic implications","author":"Wang","year":"2025","journal-title":"World J. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119574_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","article-title":"Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes","volume":"63","author":"Klein","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2026.119574_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s13105-025-01116-4","article-title":"Ceramides in non-communicable diseases: pathways, nutritional modulation, and therapeutic opportunities","author":"Ribeiro","year":"2025","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib12","article-title":"Consistent alteration of chain length-specific ceramides in human and mouse fibrotic kidneys","volume":"1866","author":"Eckes","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.biopha.2026.119574_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202300029","article-title":"Linking the unfolded protein response to bioactive lipid metabolism and signalling in the cell non-autonomous extracellular communication of ER stress","volume":"45","author":"Watt","year":"2023","journal-title":"Bioessays"},{"issue":"3","key":"10.1016\/j.biopha.2026.119574_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156624","article-title":"Sortilin drives hypertension by modulating sphingolipid\/ceramide homeostasis and by triggering oxidative stress","volume":"132","author":"Varzideh","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119574_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1656113","article-title":"Ceramide metabolism and cardiovascular risk factors: insights into therapeutic strategies","volume":"12","author":"Yang","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119574_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100552","article-title":"Association of plasma ceramide with decline in kidney function in patients with type 2 diabetes","volume":"65","author":"Gurung","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2026.119574_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100354","article-title":"Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease","volume":"25","author":"Guo","year":"2025","journal-title":"Metab. Open"},{"key":"10.1016\/j.biopha.2026.119574_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-1368-4_3","article-title":"Sphingolipid metabolism and neutral sphingomyelinases","author":"Airola","year":"2013","journal-title":"Handb. Exp. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/acs.jmedchem.0c01664","article-title":"Small molecule inhibitors targeting biosynthesis of ceramide, the central hub of the sphingolipid network","volume":"64","author":"Sk\u00e1cel","year":"2021","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib20","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41467-025-56891-x","article-title":"CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119574_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.5551\/jat.63249","article-title":"Differences in the distribution of ceramides and sphingosine among lipoprotein and lipoprotein-depleted fractions in patients with Type 2 diabetes mellitus","volume":"29","author":"Kurano","year":"2022","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.biopha.2026.119574_bib22","doi-asserted-by":"crossref","first-page":"C538","DOI":"10.1152\/ajpcell.00144.2023","article-title":"CERS6-derived ceramides aggravate kidney fibrosis by inhibiting PINK1-mediated mitophagy in diabetic kidney disease","volume":"325","author":"Wang","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119574_bib23","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s00125-018-4720-1","article-title":"Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study","volume":"61","author":"Neeland","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2026.119574_bib24","doi-asserted-by":"crossref","unstructured":"Guanshi1 Zhang, 2; Lee, Hak Joo1,2; Zhao, Qingwei1; Ragi, Nagarjunachary1; Feng, Tianqing1; Trevino, Esmeralda1; Montellano, Richard1,2; Zhang, Shiqi1; Sharma, Kumar1,2. CerS6 and C16 Ceramide in Early-Stage Diabetic Kidney Disease: Potential Role of Adenine in Podocytopathy: SA-PO0315. Journal of the American Society of Nephrology 36(10S):10.1681\/ASN.2025p26ygftr, October 2025. | DOI: 10.1681\/ASN.2025p26ygftr.","DOI":"10.1681\/ASN.2025p26ygftr"},{"key":"10.1016\/j.biopha.2026.119574_bib25","first-page":"002","article-title":"Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease","volume":"14","author":"Sas","year":"2015"},{"key":"10.1016\/j.biopha.2026.119574_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fendo.2019.00577","article-title":"The role of ceramides in insulin resistance","volume":"10","author":"Sokolowska","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119574_bib27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fphys.2019.00532","article-title":"Mitochondrial (dys)function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet","volume":"10","author":"Sergi","year":"2019","journal-title":"Front Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119574_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107734","article-title":"Role of ceramides in the pathogenesis of diabetes mellitus and its complications","volume":"35","author":"Mandal","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.biopha.2026.119574_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fendo.2020.00407","article-title":"Ceramides in adipose tissue","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2026.119574_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.622692","article-title":"Rotten to the cortex: ceramide-mediated lipotoxicity in diabetic kidney disease","volume":"11","author":"Nicholson","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"24","key":"10.1016\/j.biopha.2026.119574_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156748","article-title":"Deficiency of CFB attenuates renal tubulointerstitial damage by inhibiting ceramide synthesis in diabetic kidney disease","volume":"7","author":"Sun","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s10020-024-01020-5","article-title":"Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy","volume":"30","author":"Liu","year":"2024","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2026.119574_bib33","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.2147\/DMSO.S487815","article-title":"TFAM and mitochondrial protection in diabetic kidney disease","volume":"17","author":"Yu","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.biopha.2026.119574_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111099","article-title":"Ceramides and mitochondrial homeostasis","volume":"117","author":"Ding","year":"2024","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2465811","article-title":"Integrative analysis of mitochondrial and immune pathways in diabetic kidney disease: identification of AASS and CASP3 as key predictors and therapeutic targets","volume":"47","author":"Yu","year":"2025","journal-title":"Ren. Fail"},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12967-024-05207-6","article-title":"Aberrant expression of NEDD4L disrupts mitochondrial homeostasis by downregulating CaMKK\u03b2 in diabetic kidney disease","volume":"22","author":"Han","year":"2024","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119574_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.044903","article-title":"Exploring ceramide C16:0 as a novel biomarker and therapeutic target for atherosclerosis","volume":"15","author":"Chen","year":"2026","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2026.119574_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-08792-8","article-title":"Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymthe.2024.11.018","article-title":"C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2026.119574_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"issue":"16","key":"10.1016\/j.biopha.2026.119574_bib41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embj.201694696","article-title":"GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death","volume":"35","author":"Sborgi","year":"2016","journal-title":"EMBO J."},{"issue":"27","key":"10.1016\/j.biopha.2026.119574_bib42","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.2174\/0109298673304627240525135453","article-title":"Research progress on podocyte pyroptosis in diabetic nephropathy","volume":"32","author":"Zhu","year":"2025","journal-title":"Curr. Med Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119574_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bbamcr.2019.02.007","article-title":"Lysosomal regulation of extracellular vesicle excretion during d-ribose-induced NLRP3 inflammasome activation in podocytes","volume":"1866","author":"Hong","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"10.1016\/j.biopha.2026.119574_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fcell.2019.00259","article-title":"D-ribose induces podocyte NLRP3 inflammasome activation and glomerular injury via AGEs\/RAGE pathway","volume":"7","author":"Hong","year":"2019","journal-title":"Front Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119574_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166146","article-title":"Contribution of podocyte inflammatory exosome release to glomerular inflammation and sclerosis during hyperhomocysteinemia","volume":"1867","author":"Huang","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119574_bib46","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s10753-023-01861-y","article-title":"Regulation of NLRP3 inflammasome activation and inflammatory exosome release in podocytes by acid sphingomyelinase during obesity","volume":"46","author":"Huang","year":"2023","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.biopha.2026.119574_bib47","doi-asserted-by":"crossref","first-page":"C481","DOI":"10.1152\/ajpcell.00150.2019","article-title":"Control of lysosomal TRPML1 channel activity and exosome release by acid ceramidase in mouse podocytes","volume":"317","author":"Li","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119574_bib48","article-title":"Abnormal podocyte TRPML1 channel activity and exosome release in mice with podocyte-specific Asah1 gene deletion","volume":"1866","author":"Li","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2026.119574_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102013","article-title":"Regulation of TRPML1 channel activity and inflammatory exosome release by endogenously produced reactive oxygen species in mouse podocytes","volume":"43","author":"Li","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajpath.2021.10.005","article-title":"Exosome biogenesis and lysosome function determine podocyte exosome release and glomerular inflammatory response during hyperhomocysteinemia","volume":"192","author":"Huang","year":"2022","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119574_bib51","doi-asserted-by":"crossref","first-page":"F988","DOI":"10.1152\/ajprenal.00195.2023","article-title":"Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation","volume":"326","author":"Huang","year":"2024","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119574_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/biom15030349","article-title":"Renal implications of dysregulated protein homeostasis: insights into ubiquitin-proteasome and autophagy systems","volume":"15","author":"Delrue","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119574_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117210","article-title":"Status and role of the ubiquitin-proteasome system in renal fibrosis","volume":"178","author":"Chen","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2026.119574_bib54","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.7150\/ijms.107284","article-title":"The roles of the ubiquitin-proteasome system in renal disease","volume":"22","author":"Lu","year":"2025","journal-title":"Int J. Med Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119574_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biology9030059","article-title":"Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot","volume":"9","author":"Humbert","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2026.119574_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13679-026-00716-5","article-title":"Autophagy in obesity and Type 2 diabetes: beyond the protective paradigm","volume":"15","author":"Angarita-Pl\u00e1nchez","year":"2026","journal-title":"Curr. Obes. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2026.119574_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nm.3843","article-title":"Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models","volume":"21","author":"Schiffer","year":"2015","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.biopha.2026.119574_bib58","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.kint.2025.01.040","article-title":"A new era in nephrology: the role of super-resolution microscopy in research, medical diagnostic, and drug discovery","volume":"107","author":"Siegerist","year":"2025","journal-title":"Kidney Int"},{"issue":"195","key":"10.1016\/j.biopha.2026.119574_bib59","doi-asserted-by":"crossref","DOI":"10.3791\/65364","article-title":"Generation of patient-derived podocytes from skin biopsies","author":"Rose","year":"2023","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.biopha.2026.119574_bib60","article-title":"Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: a review of the literature","volume":"18","author":"Thipsawat","year":"2021","journal-title":"Diabetes Vasc. Dis. Re"},{"key":"10.1016\/j.biopha.2026.119574_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.06.021","article-title":"Long-chain and very long-chain ceramide levels in subjects with impaired glucose regulation","author":"Dimova","year":"2025","journal-title":"J. Clin. Lipido"},{"issue":"Pt 2","key":"10.1016\/j.biopha.2026.119574_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1113\/jphysiol.2004.066498","article-title":"Postsynaptic production of nitric oxide implicated in long-term depression at the mature amphibian (Bufo marinus) neuromuscular junction","volume":"559","author":"Etherington","year":"2004","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12944-024-02019-x","article-title":"The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib64","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1159\/000541848","article-title":"Nanocarrier-based drug delivery systems targeting kidney diseases","volume":"49","author":"Zucaro","year":"2024","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.biopha.2026.119574_bib65","first-page":"206","article-title":"Targeted therapy of kidney disease with nanoparticle drug delivery materials","volume":"37","author":"Shang","year":"2024","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.biopha.2026.119574_bib66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jat.4743","article-title":"Study of serum metabolic biomarkers and prediction models of cantharidin-induced nephrotoxicity in rats based on dynamic metabolomics","volume":"45","author":"Cheng","year":"2025","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib67","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ekir.2025.09.027","article-title":"From evidence to action: advancing timely implementation of triple therapy in Type 2 diabetes mellitus and CKD","volume":"11","author":"Fernandez-Fernandez","year":"2025","journal-title":"Kidney Int Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119574_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2496795","article-title":"Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control","volume":"57","author":"Shalaby","year":"2025","journal-title":"Ann. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:42:00Z","timestamp":1787438520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":68,"alternative-id":["S0753332226006104"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119574","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceramide: A critical lipid mediator in the progression of diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119574"}}